SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

Share Price is delayed by 15 minutes
Get Live Data
16.00    0.00 (0.00%)
Bid:
15.00
Ask:
17.00
Spread: 2.00 (13.333%)
Market Cap: £17.55m
TEAM Live PriceLast checked at - London Stock Exchange

Intraday Team Share Chart

Equity Subscription

21 Mar 2025 14:15

RNS Number : 7277B
Team PLC
21 March 2025
 

21 March 2025

 

 

("TEAM", the "Company" or the "Group")

 

Equity Subscription

TEAM plc (AIM: TEAM), the wealth, asset management and complementary financial services group, is pleased to announce that the Company is issuing 2,800,000 new ordinary shares of no par value in the Company ("Ordinary Shares"), pursuant to a direct subscription (the "Subscription") at a price of 10 pence per share, being the Company's most recent fundraising price. The new Ordinary Shares, which will represent c. 4.5 per cent. of the Company's issued shares as enlarged by the Subscription, will be issued under the Company's existing share authorities.

The proceeds of the Subscription amounting to £0.28 million will be used to provide cash for working capital and general corporate purposes.

AIM Application

Application will be made to the London Stock Exchange for admission to trading on AIM for the 2,800,000 new Ordinary Shares detailed above ("Admission"), and Admission is expected to become effective and trading will commence in the new Ordinary Shares on or around 27 March 2025. The new Ordinary Shares will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the Company's existing Ordinary Shares.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise of 61,540,022 Ordinary Shares, none of which are held in treasury. Accordingly, the figure of 61,540,022 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 For further information, please contact:

Team plc

Tel: +44 (0) 1534 877210

Mark Clubb

 

Strand Hanson (Nominated Advisor)

Tel: +44 20 7409 3494

Richard Johnson / James Spinney / David Asquith

Novella Communications (Financial PR)

Tel: +44 20 3151 7008

Tim Robertson / Safia Colebrook

team@novella-comms.com

 

 

Further information on the Company can be found on its website at www.teamplc.co.uk 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZGZFDMFGKZM
Date   Source Headline
11th May 20267:00 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSAcquisition
23rd Apr 20265:00 pmRNSHolding(s) in Company
10th Apr 202612:30 pmRNSHolding(s) in Company
10th Apr 20268:45 amRNSHolding(s) in Company
8th Apr 202610:30 amRNSHolding(s) in Company
31st Mar 20262:28 pmRNSFinal Results
30th Mar 20267:00 amRNSDouble Acquisition
24th Mar 20264:00 pmRNSIssue of new TEAM shares and Total Voting Rights
24th Mar 20263:10 pmRNSDisclosure Table
24th Mar 20263:00 pmRNSScheme becomes Effective
20th Mar 202612:20 pmRNSCourt Sanction of Scheme of Arrangement
17th Mar 20266:00 pmRNSFTSE Russell Index Changes
12th Mar 202610:20 amBUSForm 8.5 (EPT/RI) - Team Plc
6th Mar 20263:02 pmRNSRecommended Acquisition of W.H. Ireland Group plc
20th Feb 20269:50 amGNWForm 8.5 (EPT/RI) - Team Plc
18th Feb 202610:11 amGNWForm 8.5 (EPT/RI) - Team Plc
13th Feb 202611:38 amGNWForm 8.5 (EPT/RI) - Team Plc
22nd Jan 202610:37 amGNWForm 8.5 (EPT/RI) - Team Plc
21st Jan 202610:47 amGNWForm 8.5 (EPT/RI) - Team Plc
7th Jan 20264:20 pmRNSForm 8.3 - Team PLC
6th Jan 202611:11 amGNWForm 8.5 (EPT/RI) - Team Plc
30th Dec 20254:00 pmRNSDisclosure under Rule 2.10(c) of the Takeover Code
30th Dec 20254:00 pmRNSDisclosure under Rule 2.10(c) of the Takeover Code
29th Dec 20255:00 pmRNSResult of Meeting
29th Dec 20255:00 pmRNSResult of Meeting
19th Dec 20253:00 pmRNSIssue of Equity
19th Dec 20253:00 pmRNSIssue of Equity
18th Dec 202510:14 amRNSHolding(s) in Company
18th Dec 20259:45 amRNSForm 8.3 - TEAM Plc
15th Dec 20252:42 pmRNSForm 8.3 - Team Plc
12th Dec 202511:15 amRNSForm 8.3 - TEAM PLC
12th Dec 202511:10 amRNSForm 8.3 - Team PLC
12th Dec 202511:05 amRNSForm 8.3 - Team PLC
12th Dec 202511:02 amRNSForm 8.3 - Team PLC
12th Dec 202511:00 amRNSForm 8.3 - Team PLC
10th Dec 20254:30 pmRNSPosting of Team Circular and notice of Team EGM
10th Dec 202510:52 amGNWForm 8.5 (EPT/RI) - Team Plc
9th Dec 20253:30 pmRNSForm 8.3 Team PLC
9th Dec 20252:45 pmRNSForm 8.3 - Team PLC
9th Dec 20252:40 pmRNSForm 8.3 - TEAM PLC
9th Dec 20252:35 pmRNSForm 8.3 - TEAM PLC
9th Dec 20252:30 pmRNSForm 8.3 - Team PLC
9th Dec 20252:25 pmRNSHolding(s) in Company
9th Dec 20252:25 pmRNSForm 8.3 - TEAM PLC
9th Dec 20252:20 pmRNSForm 8.3 Team PLC
9th Dec 202512:08 pmRNSForm 8.3 - TEAM PLC
9th Dec 202511:00 amRNSLoan Note Extension
5th Dec 202510:01 amRNSForm 8.3 - Team PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.